Hartmann LC - Search Results

1

A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma.

Creagan ET, Schaid DJ, Hartmann LC, Loprinzi CL. Creagan ET, et al. Among authors: hartmann lc. Am J Clin Oncol. 1993 Jun;16(3):243-4. doi: 10.1097/00000421-199306000-00010. Am J Clin Oncol. 1993. PMID: 7687819 Clinical Trial.

2

A pilot study of long-acting octreotide for symptomatic malignant ascites.

Jatoi A, Nieva JJ, Qin R, Loprinzi CL, Wos EJ, Novotny PJ, Moore DF Jr, Mowat RB, Bechar N, Pajon ER Jr, Hartmann LC. Jatoi A, et al. Among authors: hartmann lc. Oncology. 2012;82(6):315-20. doi: 10.1159/000337246. Epub 2012 May 10. Oncology. 2012. PMID: 22572824 Free PMC article. Clinical Trial.

3

A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.

Ingle JN, Johnson PA, Suman VJ, Gerstner JB, Mailliard JA, Camoriano JK, Gesme DH Jr, Loprinzi CL, Hatfield AK, Hartmann LC. Ingle JN, et al. Among authors: hartmann lc. Cancer. 1997 Jul 15;80(2):218-24. doi: 10.1002/(sici)1097-0142(19970715)80:2<218::aid-cncr8>3.0.co;2-p. Cancer. 1997. PMID: 9217033 Clinical Trial.

4

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.

Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN. Ingle JN, et al. Among authors: hartmann lc. Cancer. 1999 Mar 15;85(6):1284-92. doi: 10.1002/(sici)1097-0142(19990315)85:6<1284::aid-cncr10>3.0.co;2-p. Cancer. 1999. PMID: 10189133 Clinical Trial.

5

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.

Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL. Peethambaram PP, et al. Among authors: hartmann lc. Breast Cancer Res Treat. 1999 Mar;54(2):117-22. doi: 10.1023/a:1006185805079. Breast Cancer Res Treat. 1999. PMID: 10424402 Clinical Trial.

6

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.

McDonnell SK, Schaid DJ, Myers JL, Grant CS, Donohue JH, Woods JE, Frost MH, Johnson JL, Sitta DL, Slezak JM, Crotty TB, Jenkins RB, Sellers TA, Hartmann LC. McDonnell SK, et al. Among authors: hartmann lc. J Clin Oncol. 2001 Oct 1;19(19):3938-43. doi: 10.1200/JCO.2001.19.19.3938. J Clin Oncol. 2001. PMID: 11579114

7

Systemic adjuvant therapy in women with resected node-negative breast cancer.

Hartmann LC, Marschke RF Jr, Schaid DJ, Ingle JN. Hartmann LC, et al. Mayo Clin Proc. 1991 Aug;66(8):805-13. doi: 10.1016/s0025-6196(12)61198-7. Mayo Clin Proc. 1991. PMID: 1861552 Clinical Trial.

8

Clinical options for women at high risk for breast cancer.

Hartmann LC, Sellers TA, Schaid DJ, Nayfield S, Grant CS, Bjoraker JA, Woods J, Couch F. Hartmann LC, et al. Surg Clin North Am. 1999 Oct;79(5):1189-206. doi: 10.1016/s0039-6109(05)70068-2. Surg Clin North Am. 1999. PMID: 10572558 Review.

9

Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions.

Hartmann LC, Degnim A, Schaid DJ. Hartmann LC, et al. J Clin Oncol. 2004 Mar 15;22(6):981-3. doi: 10.1200/JCO.2004.01.925. Epub 2004 Feb 23. J Clin Oncol. 2004. PMID: 14981099 No abstract available.

10

Increased risk for cancer in patients with the Peutz-Jeghers syndrome.

Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, Ahlquist DA, Podratz KC, Pittelkow M, Hartmann LC. Boardman LA, et al. Among authors: hartmann lc. Ann Intern Med. 1998 Jun 1;128(11):896-9. doi: 10.7326/0003-4819-128-11-199806010-00004. Ann Intern Med. 1998. PMID: 9634427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page